These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 34069434)

  • 1. National Antimicrobial Consumption: Analysis of Central Warehouses Supplies to In-Patient Care Health Facilities from 2017 to 2019 in Uganda.
    Namugambe JS; Delamou A; Moses F; Ali E; Hermans V; Takarinda K; Thekkur P; Nanyonga SM; Koroma Z; Mwoga JN; Akello H; Imi M; Kitutu FE
    Trop Med Infect Dis; 2021 May; 6(2):. PubMed ID: 34069434
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Antimicrobial consumption surveillance in Uganda: Results from an analysis of national import data for the human health sector, 2018-2021.
    Murungi M; Ndagije HB; Kiggundu R; Kesi DN; Waswa JP; Rajab K; Barigye M; Serwanga A; Manirakiza L; Kasujja H; Kaweesi D; Joshi MP; Namugambe J; Konduri N
    J Infect Public Health; 2023 Dec; 16 Suppl 1():45-51. PubMed ID: 37926595
    [TBL] [Abstract][Full Text] [Related]  

  • 3. National Consumption of Antimicrobials in Tanzania: 2017-2019.
    Mbwasi R; Mapunjo S; Wittenauer R; Valimba R; Msovela K; Werth BJ; Khea AM; Nkiligi EA; Lusaya E; Stergachis A; Konduri N
    Front Pharmacol; 2020; 11():585553. PubMed ID: 33192526
    [No Abstract]   [Full Text] [Related]  

  • 4. Variations in the Consumption of Antimicrobial Medicines in the European Region, 2014-2018: Findings and Implications from ESAC-Net and WHO Europe.
    Robertson J; Vlahović-Palčevski V; Iwamoto K; Högberg LD; Godman B; Monnet DL; Garner S; Weist K; ;
    Front Pharmacol; 2021; 12():639207. PubMed ID: 34220495
    [No Abstract]   [Full Text] [Related]  

  • 5. A three years antimicrobials consumption in Ethiopia from 2017 to 2019: A cross- sectional study.
    Tirfe M; Alemu A; Alemu W; Woldearegay M; Asfaw G; Gerba H; Kadi D; Fentie AM
    PLoS One; 2023; 18(4):e0284038. PubMed ID: 37023072
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Ground level utility of Access, Watch, Reserve classification: Insights from a tertiary care center in North India.
    Negi G; Kb A; Panda PK
    World J Exp Med; 2023 Dec; 13(5):123-133. PubMed ID: 38173545
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Trends in antimicrobial consumption in Bhutan.
    Tshering T; Wangda S; Buising K
    IJID Reg; 2021 Dec; 1():65-71. PubMed ID: 35757828
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antimicrobial surveillance in South Australian prisons: a pilot study.
    Dalwai A; Hillock N
    Aust Health Rev; 2024 Jul; ():. PubMed ID: 39074843
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Purchase and use of antimicrobials in the hospital sector of Vietnam, a lower middle-income country with an emerging pharmaceuticals market.
    Dat VQ; Toan PK; van Doorn HR; Thwaites CL; Nadjm B
    PLoS One; 2020; 15(10):e0240830. PubMed ID: 33079967
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Development of Antimicrobial Defined Daily Dose (DDD) for the Pediatric Population.
    Montecatine-Alonso E; Mejías-Trueba M; Goycochea-Valdivia WA; Chavarri-Gil E; Fernández-Llamazares CM; Dolz E; Gutiérrez-Urbón JM; Gallego-Fernández C; Llorente-Gutiérrez J; Gil-Navarro MV
    Antibiotics (Basel); 2023 Jan; 12(2):. PubMed ID: 36830187
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antimicrobial use among adult inpatients at hospital sites within the Canadian Nosocomial Infection Surveillance Program: 2009 to 2016.
    Rudnick W; Science M; Thirion DJG; Abdesselam K; Choi KB; Pelude L; Amaratunga K; Comeau JL; Dalton B; Delport J; Dhami R; Embree J; Émond Y; Evans G; Frenette C; Fryters S; German G; Grant JM; Happe J; Katz K; Kibsey P; Kosar J; Langley JM; Lee BE; Lefebvre MA; Leis JA; McGeer A; Neville HL; Simor A; Slayter K; Suh KN; Tse-Chang A; Weiss K; Conly J;
    Antimicrob Resist Infect Control; 2020 Feb; 9(1):32. PubMed ID: 32054539
    [TBL] [Abstract][Full Text] [Related]  

  • 12. An Assessment of the Impact of Coronavirus Disease (COVID-19) Pandemic on National Antimicrobial Consumption in Jordan.
    Al-Azzam S; Mhaidat NM; Banat HA; Alfaour M; Ahmad DS; Muller A; Al-Nuseirat A; Lattyak EA; Conway BR; Aldeyab MA
    Antibiotics (Basel); 2021 Jun; 10(6):. PubMed ID: 34207567
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Global antimicrobial resistance and use surveillance system (GLASS 2022): Investigating the relationship between antimicrobial resistance and antimicrobial consumption data across the participating countries.
    Ajulo S; Awosile B
    PLoS One; 2024; 19(2):e0297921. PubMed ID: 38315668
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antibiotic use and consumption among medical patients of two hospitals in Sierra Leone: a descriptive report.
    Lakoh S; Williams CEE; Sevalie S; Russell JBW; Conteh SK; Kanu JS; Barrie U; Deen GF; Maruta A; Sesay D; Adekanmbi O; Jiba DF; Okeibunor JC; Yendewa GA; Firima E
    BMC Infect Dis; 2023 Oct; 23(1):737. PubMed ID: 37891476
    [TBL] [Abstract][Full Text] [Related]  

  • 15. National Antibiotic Consumption for Human Use in Sierra Leone (2017-2019): A Cross-Sectional Study.
    Kanu JS; Khogali M; Hann K; Tao W; Barlatt S; Komeh J; Johnson J; Sesay M; Vandi MA; Tweya H; Timire C; Abiri OT; Thomas F; Sankoh-Hughes A; Molleh B; Maruta A; Harries AD
    Trop Med Infect Dis; 2021 May; 6(2):. PubMed ID: 34068109
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Impact of the COVID-19 pandemic on hospital antimicrobial consumption in Croatia.
    Vlahović-Palčevski V; Rubinić I; Payerl Pal M
    J Antimicrob Chemother; 2022 Sep; 77(10):2713-2717. PubMed ID: 35869875
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antibiotic consumption surveillance in rehabilitation facilities - a new task according to § 23 of the German Infection Protection Act. Data from rehabilitation facilities in the Rhine-Main area, 2016-2018.
    Heudorf U; Berres M; Schmehl C; Steul K
    GMS Hyg Infect Control; 2020; 15():Doc30. PubMed ID: 33299743
    [No Abstract]   [Full Text] [Related]  

  • 18. Antimicrobial Medicines Consumption in Eastern Europeand Central Asia - An Updated Cross-National Study and Assessment of QuantitativeMetrics for Policy Action.
    Robertson J; Iwamoto K; Hoxha I; Ghazaryan L; Abilova V; Cvijanovic A; Pyshnik H; Darakhvelidze M; Makalkina L; Jakupi A; Dzhakubekova A; Carp A; Cizmovic L; Rachina S; Radonjic V; Yusufi S; Aksoy M; Ibragimova M; Godman B; Kluge H; Pedersen HB
    Front Pharmacol; 2018; 9():1156. PubMed ID: 30890943
    [No Abstract]   [Full Text] [Related]  

  • 19. [Use of systemic antibacterial agents at a university emergency clinic in Bucharest, in the year 2008].
    Ion-Nedelcu N; Radu L; Firulescu S; Truţă E; Sîrbu M; Barbu G; Calistru P
    Bacteriol Virusol Parazitol Epidemiol; 2009; 54(1):53-8. PubMed ID: 20524396
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Helicobacter pylori antimicrobial resistance and antibiotic consumption in the low-resource Central America setting.
    Ortiz V; Estevez-Ordonez D; Montalvan-Sanchez E; Urrutia-Argueta S; Israel D; Krishna US; Romero-Gallo J; Wilson KT; Peek RM; Dominguez R; Morgan DR
    Helicobacter; 2019 Aug; 24(4):e12595. PubMed ID: 31111610
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.